aTyr Pharma, Inc.

US$6.35As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ATYRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (42.19%)
Div yield —
ROE (93.68%)
Biotechnology
Beta (5Y) 1.05
PE TTM —
TSR TTM (81.67%)
Mkt cap US$15.57M
ROIC (50.97%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.93
9.11%
(67.29%)
Hold 6|10|4|10|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.08
0.08
0.08
0.09
10.75%
5.75%
2.15%
16.26%
Revenue$M
1.529
1.504
1.472
1.541
2.81%
(2.94%)
(2.80%)
4.12%
Peers (US$15.57M)
Cap (US$)
PE
15.10M
0.082x
15.57M
—
Capital
TTM
5Y
10Y
Leveragex
1.009
2.774
2.361
EBIT/Intx
0.864
0.182
0.170
Own earn%
(65.44)
(1.85)
1.47
Sh yield%
51.71
43.53
46.36
Owners
Insiders/Inst%
11.85
49.38
Short interest%
1.30
SBC / revenue%
4.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
15–28
$1 testx
—
Incr. ROIC%
2